Caspase-3 deficiency inhibits the development and anti-tumor response of bone marrow-derived dendritic cells Authors: Jinqiang Liu, Kunli Du, Yaozhen Chen, Gaozan Zheng, Hongwei Zhang, Wen Zhang, Xingbin Hu, Fan Feng Published: 2025 ABSTRACT AbstractThis study investigated the impact of Caspase-3 gene deletion on bone marrow-derived dendritic cells (BMDCs) and their anti-tumor functions. BMDCs were generated in vitro using GM-CSF and IL-4 from Caspase-3 knockout (Casp3-KO) and heterozygous (Heter) mouse progenitors. Caspase-3 ablation reduced dendritic cell numbers in vivo and hindered BMDC generation in vitro. Casp3-KO BMDCs exhibited impaired maturation, characterized by diminished dendritic arborization and reduced expression of surface markers (CD80, CD86, CXCR4, MHCI, MHCII). Migration assays revealed Caspase-3 deficiency impaired BMDC motility both in vitro and in vivo. Critically, Casp3-KO BMDCs showed compromised capabilities in phagocytosing tumor antigens and activating naïve T cells. In vivo tumorigenicity assays demonstrated that Caspase-3 deletion undermined the ability of BMDCs to suppress tumor growth. This attenuation correlated with reduced infiltration of CD4 + and CD8 + T lymphocytes at primary tumor sites and draining lymph nodes. These findings provide novel insights into the essential role of Caspase-3 in BMDC development, maturation, migration, antigen presentation, and anti-tumor efficacy. The data suggests Caspase-3 is crucial for the optimal function of dendritic cells in initiating anti-tumor immune responses, potentially informing the development of more effective cancer immunotherapies.Keywords: Caspase-3, Dendritic cells, Maturation, Migration, Anti-tumor function Introduction Dendritic cells (DCs) of mammalians, as pivotal architects of the immune landscape, adeptly marshal immune defenses against diverse pathogens and neoplasms. They are instrumental in bridging innate and adaptive immunity, playing a vital role in inducing anti-tumor immune responses [1]. DCs excel in presenting tumor-associated antigens (TAAs) to T cells, thereby activating tumor-specific T lymphocytes that possess antineoplastic capabilities, promoting adaptive immune crusade against malignancies through the synergy of co-stimulatory molecules such as CD80 and CD86 with T cell receptors (TCR) [2, 3]. During this engagement, DCs undergo maturation and navigate towards lymph nodes, where they secrete cytokines that facilitate the activation, multiplication, and specialization of T cells into principal effector subsets [4]. These subsets include cytotoxic CD8 + T cells, armed with granzyme and perforin, and CD4 + T cells, crucial for orchestrating a potent anti-tumor response [5, 6]. Given their seminal role in kick-starting and modulating immune responses, DCs have been spotlighted as prime candidates for crafting innovative cancer immunotherapeutic modalities [7, 8]. Over the past decades, breakthroughs of DC-based cancer vaccines have been made in the field of hematological and solid tumors [9, 10]. Despite these advancements, the exploration of DC vaccines in anti-tumor applications is still nascent, with the clinical efficacy of DC-based interventions yet to reach optimal levels [11]. Therefore, a deeper dive into their distinct functionalities and the molecular underpinnings may pave the way for more efficacious cancer immunotherapy strategies. Caspase-3, as a key member of cysteine-aspartic acid protease family, is predominantly recognized for its pivotal role in apoptosis. Beyond its established contributions to cell demise, burgeoning evidence suggests Caspase-3’s involvement in a spectrum of non-apoptotic functions, including cell differentiation, proliferation, and migration [12–15]. Intriguingly, it is implicated that Caspase-3 plays a crucial role in the intricate processes of axonal and dendritic pruning, as well as in the initiation of neurite outgrowth and the development of dendrite branches [16]. More importantly, research has confirmed that that Caspase-3 exerts a critical function in immune cell homeostasis [17]. However, the specific function of Caspase-3 in the creation and operation of BMDCs remains largely unexplored. Previously, our research indicated that upregulation of the Caspase-3 gene may bolster the maturation and augment the anti-neoplastic capabilities of DCs [18]. In Caspase-3 gene-deficient mice, a significant reduction in the population of CD11c+MHCII+ dendritic cells was noted [19]. Consequently, the objective of this study is to look into the outcomes of Caspase-3 deletion on the development and anti-cancer response of BMDCs. Materials and methods Data acquisition Publicly available RNA-seq data for bone marrow–derived dendritic cells (BMDCs), accession GSE134869, were obtained from the NCBI Gene Expression Omnibus (GEO). A total of 192 samples of mouse BMDCs stimulated with various pattern recognition receptor ligands (in single, pairwise, and triplet combinations) were sequenced on an Illumina NovaSeq 6000 platform, generating 150 bp paired-end reads. Raw FASTQ files were downloaded using SRA Toolkit v2.10.8 (fasterq-dump) for subsequent quality control, alignment, and expression quantification. DEGs analysis Raw count matrices for lipopolysaccharide (LPS)–stimulated and unstimulated bone marrow–derived dendritic cell (BMDC) samples were imported into the R (v4.1.0) environment. Differential expression analysis was performed using the DESeq2 package (v1.30.1). Briefly, genes with fewer than 10 total counts across all samples were filtered out. Count data were normalized by estimation of size factors, and dispersion estimates were obtained using the default “parametric” fit. A two-group comparison design formula (~ condition) was specified to contrast LPS-treated versus control samples. Wald tests were applied to each gene to calculate log2 fold changes and p-values. P-values were adjusted for multiple testing using the Benjamini–Hochberg method. Genes with |log2 fold change| ≥ 1 and false discovery rate (FDR) < 0.05 were considered significantly differentially expressed. Visualization of results included volcano plots generated with the EnhancedVolcano package (v1.8.0). Correlation analysis Normalized expression values for Caspase-3 and all other genes were extracted from the variance-stabilized count matrix generated by DESeq2. Pairwise Pearson correlation coefficients (r) between Caspase-3 and each gene were calculated using the cor function in R (v4.1.0). Genes with an absolute correlation coefficient greater than 0.5 (|r| >0.5) were considered to exhibit strong co-expression and were flagged as candidate regulators or co-regulated targets of Caspase-3. Resulting correlation statistics were compiled into a table for downstream functional annotation and network visualization. Function enrichment analysis Caspase-3-correlated genes (|r| >0.5) were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis using the clusterProfiler R package (v3.18.1). DEG lists were entered into the enrichKEGG function with the mouse organism code (organism = “mmu”), and p-value cutoff and q-value cutoff were both set to 0.05. Enriched pathways were ranked by adjusted p-value (Benjamini–Hochberg correction) and visualized using the dotplot function in clusterProfiler and ggplot2 (v3.3.3). Significant pathways (adjusted p < 0.05) were reported for biological interpretation. Protein–protein interaction (PPI) network Genes were uploaded to the STRING database (v11.5; https://string-db.org) with organism set to Homo sapiens and a combined score threshold ≥ 0.4 to construct a medium-confidence protein–protein interaction (PPI) network, which was then exported as an interaction table for subsequent network topology and functional analyses. Mice and cells Male C57BL/6 wild-type mice (aged 7–8 weeks) were sourced from the Animal Resources Center of the Fourth Military Medical University (Xi’an, China). Caspase-3 gene knockout mice (Caspase-3−/−, referred to as Casp3-KO; and Caspase-3+/−, referred to as Heter), with a C57BL/6 genetic background, were bred and maintained according to previously published protocol [14] and genotyped using polymerase chain reaction (PCR) [20]. Experimental mice were acclimatized in pathogen-controlled facilities adhering to sterile environmental protocols. All animal-related research protocols underwent rigorous ethical evaluation and were formally authorized by the Institutional Animal Ethics Review Board at the Fourth Military Medical University, in accordance with the laboratory animal management regulations. The DC2.4 murine dendritic cell line and HEK-293T human embryonic kidney cell line were procured from Huiying Biological Technology (China), and B16 mouse melanoma cells were kindly supplied by Dr. Y.Z. Chen’s research group; naïve T cells were isolated from the spleens of 6–8-week-old C57BL/6 mice using magnetic-activated cell sorting (MACS; STEMCELL Technologies, Canada). For propagation, 2.5–5 × 10^5 cells were seeded into plastic T25 flasks in RPMI-1640 medium (Gibco, USA) supplemented with 10% heat-inactivated fetal bovine serum and 1% antibiotic-antimycotic solution, all reagents from Gibco, and maintained at 37 °C in a humidified incubator with 5% CO₂. Cells were passaged at 80–90% confluence by treatment with 0.25% trypsin–EDTA for 2–3 min at 37 °C, neutralized with complete medium, pelleted at 300×g for 5 min, and reseeded at a 1:3–1:5 split ratio, with viability and morphology assessed by trypan blue exclusion before each experiment. Freshly isolated naïve T cells were activated at 1 × 10^6 cells/mL in RPMI-1640 complete medium on 96-well plates pre-coated with anti-CD3 (2 µg/mL) and anti-CD28 (1 µg/mL) antibodies for 24 h under the same incubation conditions. All procedures adhered to institutional and national ethical guidelines. BMDCs were prepared using established protocols [21]. The procedure initiated with sterile extraction of bone marrow from tibial and femoral tissues of 7-8-week-old Casp3-deficient or heterozygous C57BL/6 mice. Following this, meticulous debridement of musculoskeletal components was performed, with subsequent longitudinal sectioning of osseous structures to facilitate marrow expulsion using PBS irrigation through a 25-gauge needle. The extracted marrow cells underwent red blood cell lysis with Ammonium-Chloride-Potassium (ACK) buffer. Primary cultures were established in RPMI-1640 basal medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum, antibiotic/antimycotic solution (1% P-S), and a cytokine cocktail containing recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF, 20 ng/mL) and interleukin-4 (IL-4, 10 ng/mL) (both from PeproTech). Medium was replaced on days 3 and 6. On day 8, non-adherent BMDCs were collected and either resuspended in fresh medium for downstream use or stimulated with lipopolysaccharide (LPS, 1 µg/mL, Sigma-Aldrich) for 12 h to induce maturation. All mice requiring sacrifice were first placed in a clear, sealed chamber where CO₂ was introduced at a displacement rate of 20% of the chamber volume per minute until breathing ceased. After respiratory arrest, CO₂ flow continued for an additional 2–3 min to ensure death, followed by cervical dislocation to confirm euthanasia. For any procedures requiring anesthesia, isoflurane was administered via a calibrated vaporizer (2–3% for induction, 1–2% for maintenance) with oxygen as the carrier gas. For experiments needing immediate tissue collection, mice were anesthetized with isoflurane and then euthanized by cardiac puncture exsanguination under deep anesthesia. All procedures were performed by trained personnel in a well-ventilated area in strict accordance with IACUC and AVMA guidelines. Flow cytometry analysis and reagents A total of 5 × 10⁵ cells were resuspended in PBS containing 1% FBS and 0.1% sodium azide (NaN₃), then incubated with designated antibodies for 30 min at 4 °C in the dark. Following triple rinsing with pre-chilled phosphate-buffered saline (PBS), fluorescently labeled cellular specimens were subjected to flow cytometric analysis employing a BD FACSCanto Plus system (BD Biosciences). Quantitative data interpretation was performed using FlowJo analytical software. For comprehensive surface marker profiling, the following fluorochrome-conjugated monoclonal antibodies were utilized: FITC-conjugated anti-CD11c (11–0114), APC-conjugated anti-CD11c (17–0114), anti-MHCI (17-5958), anti-MHCII (12-5321), anti-CD80 (17–0801), anti-CD86 (17–0862), anti-CXCR4 (17-9991), anti-CD3 (17–0032), anti-CD4 (17–0042), anti-CD8 (47–0081), and anti-CD19 (17–0193). These antibodies were sourced from eBioscience or Invitrogen (USA). Cellular apoptosis quantification was performed through dual-color fluorescence labeling with phycoerythrin-conjugated Annexin V and 7-aminoactinomycin D (7-AAD) detection reagents (BD Pharmingen, San Diego, CA), utilizing flow cytometric analysis according to the manufacturer’s standardized protocols. Antigen phagocytosis assay The B16 antigens were labeled with CM-Dil dye as follows: after washing B16 cells with PBS, they were resuspended in Hanks’ Balanced Salt Solution (HBSS). CM-Dil dye (Invitrogen) was then added to the cell suspension to achieve a final concentration of 1.5 µg/mL, followed by gentle mixing. The cells were incubated in dark at 37 °C for 4 min and subsequently at 4 °C for 15 min. After incubation, the cells were collected and resuspended in PBS at a concentration of approximately 5 × 107/mL, then subjected to freeze-thaw cycles 5 times to ensure cell disruption. After centrifugation, the supernatant, containing the CM-Dil labeled B16 antigen, was aliquoted and stored at -80 °C for subsequent experimentation. The CM-Dil-labeled B16 antigen was introduced to the BMDCs culture system in a 2:1 antigen-to-BMDC ratio, and then incubated for 24 h. The uptake of labeled antigen by BMDCs was quantified using flow cytometry. Cell migration assay To assess BMDC migration in vitro, a Transwell (24-well format, 8.0 μm pore size; Corning Inc.) was utilized. LPS-treated BMDCs (1 × 10⁵ cells in 100 µl) were seeded into the upper compartment, while the lower compartment contained 600 µl of RPMI-1640 medium supplemented with 20% FBS and 100 ng/mL SDF-1α (Peprotech, USA) as the chemoattractant. After incubating for 24 h at 37 °C, cells that had traversed to the underside of the membrane were fixed using 4% paraformaldehyde for 15 min at room temperature, followed by staining with 0.1% crystal violet for 5 min. Migrated cells were then visualized and counted using a microscope (Olympus, Japan). To evaluate the in vivo migration capacityl, bone marrow-derived dendritic cells (37 ° C, 5% CO2) were activated by antigen loading with B16 melanoma lysate at a cell ratio of 1:2 for 12 h. Following triple-washed purification (300×g centrifugation, 5 min) and resuspension in sterile PBS (1 × 10⁷ cells/mL), cellular specimens were fluorescently tagged with carboxyfluorescein succinimidyl ester (CFSE, 5 µM working concentration; BD Biosciences). A standardized inoculum containing 2 × 10⁶ cells in 40 µL sterile PBS was administered via unilateral hind paw injection in C57BL/6 mice. After 12-h migration period, ipsilateral lymph nodes were dissected post-euthanasia for preparing single-cell suspensions. CFSE+ cell populations (the migrated BMDCs) were quantitatively enumerated through flow cytometric detection using FACSDiva software. T-Cell proliferation assay BMDCs (2 × 105/well) were primed with B16 antigen at a 1:2 ratio in 96-well plates for 12 h, then co-cultured at a 1:5 ratio with CFSE-labeled naive T cells. These T cells were procured from mouse spleens using a negative selection kit (STEMCELL, Canada). Following a 5-day incubation, the proliferation of APC-anti-CD3 + T cells was assessed via flow cytometry. The proportion of CD3 + T cells exhibiting diminished CFSE fluorescence intensity served as an indicator of the BMDCs’ capacity to foster T cell proliferation in vitro. Cytotoxic T lymphocyte (CTL) assay In the in vitro experiment, BMDCs treated with B16 antigens were incubated with naive T cells at a 1:5 ratio in a 96-well plate for 72 h. Following this co-culture, B16 tumor cells were introduced at a ratio of 1:40 and cultured together for another 48 h in RPMI 1640 medium without serum. After incubation, the supernatants were collected, and lactate dehydrogenase (LDH) levels were measured using a colorimetric LDH detection kit (Solarbio, China). Following in vivo immunization protocols, B16-loaded BMDCs were administered via subcutaneous injection into the left lower quadrant of the abdominal region in wild-type C57BL/6 mice (8–10 weeks old, male). After seven days, T cells were isolated from the draining lymph nodes near the injection site using magnetic-activated cell sorting (MACS). These T cells were then co-cultured with B16 tumor cells at a ratio of 40:1 in 96-well plates for 48 h in RPMI 1640 medium without serum. Following incubation, supernatants were collected and LDH activity was quantified using a commercial LDH assay kit. In vivo tumor growth assay B16 cells combined with B16 antigen-loaded BMDCs (either Caspase-KO or Heter) were administered subcutaneously into C57BL/6 mice. Tumor dimensions were recorded starting from the fifth day post-injection, and the measurements were taken with a two-days interval. Tumor volume was estimated using the formula V = L × W² × 0.52, where L represents tumor length and W denotes tumor width [22]. On day 13 following injection, the mice were euthanized in accordance with humane endpoints. Subsequently, the tumors were surgically removed, and their weights were determined. Flow cytometry was employed to quantify the infiltration ratios of T cells (CD4+ and CD8+) and B cells (CD19+) within the tumors and the draining lymph nodes of the mice. Real-time PCR and western blot RNA isolation from BMDCs was conducted with TRIzol reagent (Invitrogen, Carlsbad, CA) following established molecular protocols. First-strand complementary DNA (cDNA) synthesis was achieved using the QuantiTect Reverse Transcription system (Qiagen, Hilden, Germany) with integrated genomic DNA elimination. Amplification reactions were performed in triplicate using SYBR Premix EX Taq II (Takara, China) on a CFX96 Touch thermocycler (Bio-Rad, Hercules, CA), Caspase-3 transcript quantification employed specifically designed primers: forward (5ʹ-GGCCTGAAATACCAAGTCAGGAA-3ʹ) and reverse (5ʹ-CCATGGCTTAGAATCACACACACA-3ʹ). BMDCs were lysed using RIPA buffer (Beyotime, China), and total protein concentration was measured with a BCA assay kit (Thermo Fisher Scientific, USA). Equal amounts of protein samples were resolved by SDS-PAGE and subsequently transferred to PVDF membranes. Western blotting was then carried out using primary antibodies against Caspase-3 (1:1000; Cell Signaling Technology, USA) and β-actin (1:1000; Sigma-Aldrich, USA). Appropriate HRP-conjugated secondary antibodies (anti-rabbit or anti-mouse IgG, 1:3000; Sigma-Aldrich, USA) were applied. Protein signals were detected using a chemiluminescence imaging system (Amersham, USA). Statistical analysis The experimental results are expressed as average values along with standard deviation (SD). Significance levels were assessed by applying either one-way ANOVA or Student’s t-test, with method selection based on dataset characteristics and experimental design criteria. A probability threshold of P < 0.05 served as the cutoff for establishing statistical relevance. All analytical procedures were executed using GraphPad Prism software (v6.0) following standard statistical protocols. Results Caspase-3 upregulation in BMDCs and association with cytokine Analysis of the GSE134869 dataset revealed that Caspase-3 expression is significantly upregulated in bone marrow–derived dendritic cells (BMDCs) (Fig. 1A). Correlation analysis within this dataset identified 163 genes whose expression levels exhibit a strong positive correlation with Caspase-3. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis of these Caspase-3-associated genes demonstrated a pronounced enrichment in cytokine-related signaling pathways (Fig. 1B). Caspase-3 is highly expressed in BMDCs and affects the cytokine-related pathways of BMDC cells. A the differential expression volcano plot shows that Caspase-3 is highly expressed in BMDCs stimulated by LPS. B genes related to Caspase-3 are mainly enriched in the chemokine signaling pathway. C Protein interaction analysis shows that Caspase-3 interacts with multiple marker genes To further elucidate the molecular interplay between Caspase-3 and cytokine networks, we constructed a protein–protein interaction (PPI) network incorporating Caspase-3 and key classical cytokine markers—CD80, CD86, CXCR4, MHC I, and MHC II (Fig. 1C). The resulting network highlighted multiple direct and indirect interactions between Caspase-3 and these cytokine molecules, underscoring a potential mechanistic link by which Caspase-3 may modulate dendritic cell cytokine function. Caspase-3 gene knockout inhibited DCs generation To generate BMDCs, mouse bone marrow cells were co-stimulated with GM-CSF (20 ng/mL) and IL-4 (10 ng/mL). Following an 8-day culture, Lipopolysaccharides (LPS, 1 µg/mL) were introduced to induce maturation of the BMDCs. The expression of surface markers MHCII+ CD11c+ was subsequently evaluated (Fig. 2A). The levels of Caspase-3 mRNA and protein in BMDCs derived from caspase3-/- (casp3-KO) and caspase3-/+ (Heter) mice were quantified using real-time PCR and Western blot analysis, respectively. The analyses revealed significantly diminished mRNA and protein expression levels of Caspase-3 in BMDCs from the casp3-KO group when compared to those from the Heter group (Fig. 2B and C), indicating the successful cultivation of BMDCs from both genotypes. Analysis of caspase-3 gene knockout on the generation and apoptosis of mouse dendritic cells. A Phenotypic validation of BMDCs induced by mouse bone marrow cells. B, C Caspase-3 mRNA and protein level of Casp3-KO and Heter BMDCs were detected through RT-qPCR and western blotting respectively. D The proportion of MHC II+CD11c+ cells in bone marrow, spleen, and abdominal draining lymph node from Casp3-KO and Heter mice. E The cell colonies of BMDCs induced from bone marrow cells of Casp3-KO and Heter mice. F, G BMDCs apoptosis before and after LPS stimulation in the Casp3-KO and Heter groups. All experiments were performed independently three times; data are presented as mean ± SD. NS: not statistically significant, ***P<0.001 To ascertain the role of Caspase-3 in DC generation, the proportion of DCs (MHC II+CD11c+) from both Casp3-KO and Heter mice was evaluated. Flow cytometry results showed a decrease in the frequency of MHCII+ CD11c+ cells in the Casp3-KO group compared to the Heter group in bone marrow, spleen, and abdominal draining lymph nodes (Fig. 2D). Additionally, the capacity for colony formation by BMDCs sourced from the bone marrow of Casp3-KO mice was notably impaired (Fig. 2E), suggesting that Caspase-3 deletion inhibits DC generation. Given Caspase-3’s integral role in apoptosis, we further scrutinized the apoptosis profiles of BMDCs subsequent to Caspase-3 gene deletion. Comparative apoptotic analysis between Casp3-KO and Heter BMDCs with LPS stimulation, unveiled no significant difference (Fig. 2F, G). Caspase-3 gene knockout inhibited the formation of dendrites and the surface marker expression of mature BMDCs The maturation of dendritic cells is epitomized by the development of dendrites and surface molecule expression. To discern the effects of Caspase-3 deletion on the maturation of BMDCs, we examined dendrite formation pre- and post-LPS stimulation via electron microscopy. Prior to LPS stimulation, both groups displayed the sparse, thick, and short dendrites on surface (Fig. 3A), with no significant difference in dendrite counts (Fig. 3B). After LPS induction, an appreciable surge in dendritic proliferation was observed in both cohorts. Notably, in the Casp3-KO group, dendrites were shorter (Fig. 3A), and their abundance was significantly less compared to that of Heter group (Fig. 3C), suggesting that Caspase-3 gene knockout impedes the full-fledged dendritic expansion in maturation of BMDCs. DCs maturation determination after Caspase-3 gene knockout. A The dendrite formation of BMDCs in Casp3-KO and Heter group before and after LPS stimulation under scanning electron microscope. B, C The dendrite counts of BMDCs based (A). D Expression levels of surface molecules (CD80, CD86, CXCR4, MHC I, MHC II) of BMDCs stimulated by LPS in Casp3-KO and Heter group. E, F Expression levels of surface molecules (CD80, CD86, CXCR4, MHC I, MHC II) of CD11c+ cell in spleen and abdominal draining lymph nodes between Casp3-KO and Heter mice. All experiments were performed independently three times; data are presented as mean ± SD. NS: not statistically significant, *P<0.05 Dendritic cell maturation, evidenced by dendritic changes, also involves elevated expression of co-stimulatory molecules like CD80 and CD86. Therefore, we examined the surface molecules on BMDCs post-LPS stimulation. It was observed that the levels of CD80, CD86, CXCR4, MHC I, and MHC II were significantly lower in the Casp3-KO group compared to that of the Heter group (Fig. 3D). Additionally, when assessing surface marker of CD11c+ cells in the spleen and abdominal draining lymph nodes of both groups, a pronounced decrease was evident in the spleen cells of the Casp3-KO group compared to the Heter group (Fig. 3E), with similar trends in the abdominal draining lymph nodes, albeit with a marked increase in CXCR4 expression in the Heter group (Fig. 3F). These results demonstrate that Caspase-3 gene knockout retarded the maturation of BMDCs. Caspase-3 gene knockout weakened the antigen phagocytosis and migration ability of BMDCs As professional antigen-presenting cells, BMDCs are responsible for capturing and presenting antigens. Here B16 cells were labeled to produce Dil-labeled B16 antigens through successive freeze-thaw cycles (Fig. 4A). These antigens were then co-cultured with both immature and mature BMDCs from Casp3-KO and Heter groups. The results indicated that the antigen phagocytic capability of immature BMDCs markedly surpassed that of mature BMDCs post-LPS stimulation, with the frequency of Dil + cells being significantly higher in the Heter group than that of the Casp3-KO group (Fig. 4B, C). Even after LPS stimulation, which generally reduced the phagocytic capacity across both groups, the difference remained pronounced (Fig. 4B, C), suggesting that Caspase-3 deletion damaged antigen uptake capacity of BMDCs. The antigen phagocytosis and migration investigation on BMDCs after Caspase3 gene knockout. A CM-Dil dye was used to label B16 cells. B16-nake: control group, B16-Dil: CM-Dil positive B16 cells after staining. B, C B16 tumor antigens labeled with Dil were co-cultured with mature/immature Casp3-KO and Heter BMDCs for 24 h, and the proportion of Dil + cells was detected by flow cytometry. D, E Transwell assay of BMDCs in two groups. F, G B16 tumor antigens loaded BMDCs were stained with CFSE, and then injected into hind footpads of C57BL/6 mice. The migrated BMDCs (defined as CFSE-positive cells) in the popliteal lymph node were detected by flow cytometry after 12 h. All experiments were performed independently three times; data are presented as mean ± SD. *P<0.05 The observed decrease in CXCR4 in Caspase-3 gene knockout BMDCs promoted us to postulate a potential impairment of migration. To verify that, we evaluated BMDC migration both in vitro and vivo assay. The Transwell assay revealed a significant reduction in the migration of Casp3-KO group BMDCs (Fig. 4D, E). And the in vivo data demonstrated a considerable decrease in the number of migrating BMDCs (identified as FITC+ cells) in the Casp3-KO group (Fig. 4F, G), affirming that Caspase-3 deficiency hampers the migratory capabilities of BMDCs. Caspase-3 gene knockout impeded the ability of BMDCs to activate naive T cells Dendritic cells play an instrumental role in directly activating naive T cells, thus orchestrating anti-tumor immune responses. In pursuit of understanding this mechanism in our system, naive T cells were isolated from mouse spleens (Fig. 5A), labeled with CFSE, and subsequently co-cultured with B16 antigen-loaded BMDCs. We then explored the outcomes of Caspase-3 deletion on the BMDCs’ capability to activate and proliferate naive T cells. Our findings revealed that BMDCs laden with tumor antigen were proficient in instigating naive T cell proliferation in vitro. Nonetheless, the proliferation rates of T cells co-cultured with Casp3-KO BMDCs were significantly diminished compared to those of in the Heter group (Fig. 5B, C). The analysis of BMDCs’ ability to activate naive T cells after Caspase-3 gene knockout. A Naïve T lymphocytes were purified from murine splenic tissues through magnetic-activated cell sorting (MACS) with negative selection protocols. B, C BMDCs loaded with B16 tumor antigens were cultured together with CFSE-stained naïve T lymphocytes obtained from splenic preparations. CD3 + lymphocyte proliferation was assessed via flow cytometry following 5-day incubation. D In vitro-activated T cells stimulated by tumor antigen-presenting BMDCs were incubated with B16 tumor cells. LDH in the supernatants were detected 48 h later. E Tumor antigen-loaded BMDCs were administered via subcutaneous injection into the left lower abdomen region of C57BL/6 mice. Seven days post-immunization, Activated T cells were isolated from draining lymph node and co-cultured with B16 tumor cells. LDH in the supernatants were detected 48 h later. All experiments were performed independently three times; data are presented as mean ± SD. *P<0.05, **P<0.01 Activated T cells, primed by tumor antigens presented by BMDCs, engage in anti-tumor activities through antigen-specific cytotoxic responses. Then we evaluated the cytotoxic abilities of T cells activated by BMDCs. Our analyses demonstrated that T cells activated by Casp3-KO BMDCs exhibited notably lower cytotoxicity compared to those of Heter BMDCs in vitro (Fig. 5D). Correspondingly, T cells from the draining lymph nodes, activated vi.a. subcutaneous injection of Casp3-KO BMDCs, showed significantly reduced cytotoxicity in comparison to those from the Heter group (Fig. 5E). These findings suggest that Caspase-3 deletion hinders BMDCs’ ability to foster naive T cell proliferation and attenuates the specific cytotoxic functions of T cells activated by BMDCs. Caspase-3 gene knockout impaired the ability of BMDCs to suppress tumor growth in vivo To investigate the capacity of bone marrow-derived dendritic cells (BMDCs) to interference tumor growth in vivo after Capase-3 gene knockout, B16 cells alongside B16 antigen-loaded BMDCs from either the Casp3-KO or Heter groups were co-injected subcutaneously into the abdominal wall of wild-type (WT) mice. The results showed that a significantly accelerated tumor growth in the Casp3-KO group compared to that of the Heter group (Fig. 6A). Thirteen days post-tumor induction, the mice were sacrificed, and both the tumor neoplasmand the tumor-draining lymph nodes from the lateral abdominal wall were collected. Observations revealed that tumor neoplasm with Casp3-KO BMDCs were notably larger and heavier (Fig. 6B), whereas the corresponding tumor-draining lymph nodes were smaller in comparison to those in the Heter group (Fig. 6C). Tumor growth with BMDCs after Caspase-3 gene knockout in vivo. A B16 tumor cells and B16 antigen loaded BMDCs of Casp3-KO / Heter groups were co-injected subcutaneously into the abdominal wall of WT C57BL/6 mice. Tumor length and width were measured and tumor volume were calculated. B, C 13 days later, tumor and tumor-draining lymph node was dissected, and the tumor weight was measured. D, E Proportion of CD4+T cell, CD8+ T cells and CD19+ B cells in the tumor tissue of two groups. F, G Proportion of CD4+T cell, CD8+ T cells and CD19+ B cells in the tumor-draining lymph nodes of two groups. All experiments were performed independently three times; data are presented as mean ± SD. NS: not statistically significant, *P<0.05, **P<0.01 Further examination aimed to elucidate the infiltration of CD4+ T cells, CD8+ T cells, and CD19+ B cells within the tumor tissues and tumor-draining lymph nodes. The analysis demonstrated significantly reduced infiltrations of both CD4+ and CD8+ T cells in tumors co-injected with Casp3-KO BMDCs compared to those with Heter BMDCs (Fig. 6D), while the infiltration of CD19+ B cells remained comparable between these two groups (Fig. 6E). Similar infiltration patterns were observed in the tumor-draining lymph nodes (Fig. 6F and G). These findings imply that the impediment to tumor growth is closely linked with the enhanced infiltration of CD4+ and CD8+ T cells. Collectively, these results reveal that Caspase-3 gene knockout markedly diminishes the efficacy of BMDCs in curbing tumor growth in vivo, primarily through reducing CD4+ and CD8+ T lymphocyte infiltrations in both the tumor and tumor-draining lymph nodes. Discussion In the present study, the deletion of the Caspase-3 gene was found to impair the maturation and attenuate the anti-tumor immune response of BMDCs. Specifically, the absence of Caspase-3 led to a reduced generation of BMDCs and hindered the formation of surface dendrites. Additionally, the expression levels of crucial surface molecules on BMDCs, including MHCI, MHCII, CD80, CD86, and CXCR4, were notably diminished. Furthermore, the capabilities of BMDCs to phagocytose antigens, migrate, and activate naive T cells for tumor eradication were compromised. We believe these findings are significant to tumor pathology, as well as therapy development based on DCs. Caspase-3 is recognized not merely as a pivotal enzyme in the process of apoptosis but also as an essential participant in cell proliferation and development [15, 23]. Yosefzon et al. demonstrated that the absence of Caspase-3 results in impaired epidermal cell proliferation and reduced organ size in sebaceous glands [24]. Similarly, double mutant mice lacking both Caspase-3 and caspase-7 exhibit lighter hearts with cardiomyocyte hypertrophy and reduced numbers of myocytes [25]. It was even observed that Caspase-3−/− mice exhibit smaller body sizes compared to their wild-type (WT) counterparts [26]. However, this phenomenon was not observed in our experiment. In contrast, another study using gene knockout mouse models have shown that Caspase-3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady state [27]. It is worth noting that the mouse model lacking expression of Caspase-3 showed an increase in the number of splenic B lymphocytes in vivo, and also showed a hyperproliferative response following in vitro stimulation [28]. Previous studies have shown that Caspase-3 may exhibit cell or condition-specific heterogeneity in regulating cell proliferation [15, 29, 30]. Caspase-3 also plays a crucial role in cell differentiation and maturation, independent of any evidence indicating apoptosis activation. Mice deficient in Caspase-3 exhibit abnormalities in osteogenic and cardiac muscle differentiation [25, 31]. Additionally, Caspase-3 has been reported to regulate the differentiation and maturation of various myeloid cells, including monocytes and mast cells, highlighting its broad impact across different cell types [32]. Our previous research indicates that the overexpression of Caspase-3 in DC2.4 does not result in a significant increase in apoptosis but promotes cell maturation [18]. This study further underscores this viewpoint from another perspective, revealing that Caspase-3 knockout inhibits the development and maturation of BMDCs, with no significant effect on cell apoptosis. Nevertheless, the precise molecular pathways by which caspase-3 regulates cellular proliferation independently of apoptosis remain incompletely defined. Previous studies indicate two potential mechanisms: a “nonautonomous” route—whereby apoptotic bystander cells release caspase-3–dependent paracrine factors that stimulate neighboring cell division—and a “cell-autonomous” route involving direct, intracellular actions of caspase-3 [29]. On the contrary, the latter mechanism requires activation of the sub apoptotic Caspase-3, which directly controls proliferation by cleaving key cell cycle regulatory factors including ROCK1, α - catenin, and iPLA2 [15]. Among Caspase-3 targets are known regulators of cell cycle checkpoints [33]. Notably, multiple Caspase-3 targets identified in programmed cell death contexts - particularly cell cycle checkpoint controllers - have been shown to orchestrate cell cycle even when apoptotic machinery remains inactive [24, 33]. The maturation of dendritic cells is a key step in their anti-tumor immune function, and significant morphological changes in dendritic structures are one of the typical markers. Previous studies on the regulation of dendrite formation by Caspase-3 have mainly focused on neuronal cells. Research on neural cell differentiation in the olfactory bulb of rats indicates that Caspase-3 activation may influence neuron proliferation, differentiation, dendrite formation, and migration [34]. Erturk et al. demonstrated that significant changes in the dendrites and spines of hippocampal neurons in mice under Mito-Killer Red light stimulation were closely linked to the activation of Caspase-3 [35]. Chen et al. found that chronic cerebral hypoperfusion lead to reduced length, number, and intersections of dendrites in hippocampal and cortical neurons in rats, accompanied by increased Caspase-3 activation [36]. During early neural development, Caspase-3 contributes to changes in neuronal structure and function, particularly in pruning axons, dendrites, and synaptic connections [37, 38]. Recent research on Autism Spectrum Disorders found that inhibiting Caspase-3 largely reversed morphological changes in dendrites, axons, and spines, along with alterations in inhibitory synaptic puncta [39]. Caspase-3 activity is essential for BMDC maturation, as its deletion leads to reduced dendritic branching and diminished CD80, CD86, CXCR4, MHC I, and MHC II expression. Inhibition of caspase activity in superantigen-stimulated monocytes markedly impairs CD80 induction, demonstrating a caspase-3–dependent requirement for costimulatory molecule upregulation [40]. Likewise, caspase-3–mediated cleavage of NF-κB and related signaling intermediates modulates cytokine receptor and CD86 expression thresholds, suggesting a similar mechanism for CXCR4 downregulation [41]. Furthermore, reduced MHC II levels in plasmacytoid DCs undergoing caspase-3–dependent apoptosis imply that caspase-3 directly influences antigen-presentation machinery, consistent with our observations of decreased MHC I and MHC II in casp3-knockout BMDCs [42]. The specific mechanisms by which Caspase-3 regulates neuronal and synaptic development remain unclear. Previous studies have shown that cytoskeletal remodeling plays an important role in the cell cycle, apoptosis, and the development of dendritic spines in neurons [43, 44]. The reorganization patterns of cytoskeletal proteins vary under different conditions, resulting in different effects on the cell. For example, in cerebellar granule cells (CGCs), potassium deprivation (K5) treatment leads to damage to the cell body while preserving the neurites relatively intact. In contrast, staurosporine (STS) treatment causes early changes in the neurites [45]. In this study, for the first time, we found that Caspase-3 is involved in regulating dendritic development of BMDCs. Researches indicate that cytoskeletal reorganization also plays a crucial role in dendritic cell maturation and dendrite development [46, 47]. Our previous study showed that RBP-J (the key transcription factor of Notch) deficient BMDCs have less dendrites, and exhibited less cytoskeleton reorganization upon contacting T cells [48, 49]. Furthermore, research has confirmed that Notch signaling activation positively regulates Caspase-3 [50]. Therefore, we hypothesize that the regulation of dendrite development in BMDCs by Caspase-3 may be related to cytoskeletal reorganization, but this needs to be further confirmed. Critically, our study noted a significant reduction in the activation of naive T cell proliferation and the tumor-killing efficacy of BMDCs following Caspase-3 knockout, resulting in a diminished capacity of BMDCs to suppress tumor growth in vivo. Further analyses revealed a decrease in CD4+ and CD8+ T cell infiltration into primary tumor sites in the Casp3-KO BMDCs injection group. It has been previously shown that DCs within tumor environments can produce CXCL9 and CXCL10, which are crucial for recruiting activated effector CD8+ T cells and CD4+ Th1 cells from draining lymph nodes to the tumor site for cancer cell elimination [51]. The potential impact of Caspase-3 knockout on the production of these chemokines by BMDCs requires further investigation. This study has several limitations. Firstly, we utilized bone marrow cells from Caspase-3 knockout mice to generate BMDCs in vitro, rather than establishing dendritic cell-specific Caspase-3 knockout mice. This approach may cause the cells to lose some inherent characteristics during cultivation. Additionally, the functionality explored in BMDCs might not comprehensively represent the functions of dendritic cells in vivo. The study also did not explore the effects of Caspase-3 overexpression in BMDCs. Lastly, the specific mechanisms by which Caspase-3 affects the development and anti-tumor functions of BMDCs remain relatively superficial and require further in-depth study. Conclusion In summary, our investigation has elucidated the critical involvement of Caspase-3 in the maturation and anti-neoplastic efficacy of dendritic cells (DCs). The results underscore the pivotal role of Caspase-3 in the regulation of bone marrow-derived dendritic cells (BMDCs) development, locomotion, and anti-carcinogenic immunity. These provide a potential target for optimizing DC-based cancer vaccines by regulating Caspase-3 activity. Author contributions JQ.L. performed most of experiments. JQ.L.and KL.D. interpreted data and drafted the manuscript. YZ.C. helped to conduct animal experiments and interpreted data. GZ.Z. helped to record data. HW.Z. and W.Z. modified the manuscript. F.F. and XB.H.designed and supervised the research. All authors read and approved the final manuscript. Funding This research was funded by the Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases (No. 2023-KFZD-2). Data availability The datasets generated and analyzed during the present study are available from the corresponding author on reasonable request. Declarations Ethics approval All animal experimental procedures in this study were strictly conducted in accordance with the laboratory animal management regulations and were approved by the Institutional Animal Ethics Review Board of the Fourth Military Medical University(IACUC-20230149). Consent to participate declaration. Not applicable. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Jinqiang Liu, Kunli Du and Yaozhen Chen contributed equally to this work. Contributor Information Xingbin Hu, Email: hxbyqh@163.com. Fan Feng, Email: surgeonfengfan@163.com. References Associated Data Data Availability Statement The datasets generated and analyzed during the present study are available from the corresponding author on reasonable request.